V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16626011 | 330006387 | EEI00 | 8 | X722 | 1 | 2014-03-13 | MESNA | 330001399 | 330003170 | 330006387 |
| 16626012 | 330006387 | EK1EN | 3840 | null | 1 | 2014-03-13 | DOXORUBICIN | 330001399 | 330003170 | 330006387 |
| 16626013 | 330006387 | EUZ | 76 | X721 | 1 | 2014-03-14 | CYTARABINE | 330001399 | 330003170 | 330006387 |
| 16626014 | 330006387 | E1UZ0 | 120 | null | 1 | 2014-03-14 | DOXORUBICIN | 330001399 | 330003170 | 330006387 |
| 16626015 | 330006388 | EEI00 | 22 | null | 1 | 2014-02-14 | TOPOTECAN | 330001423 | 330003171 | 330006388 |
| 16626016 | 330006388 | EPH | 2 | X724 | 1 | 2014-02-15 | NOT CHEMO | 330001423 | 330003171 | 330006388 |
| 16626017 | 330006389 | EEI00 | 860 | X729 | 1 | 2013-11-14 | TRIAL | 330001423 | 330003171 | 330006389 |
| 16626018 | 330006389 | EOF | 58 | X721 | 1 | 2013-11-14 | METHOTREXATE | 330001423 | 330003171 | 330006389 |
| 16626019 | 330006389 | E0N03 | 200 | x724 | 1 | 2013-11-15 | RITUXIMAB | 330001423 | 330003171 | 330006389 |
| 16626020 | 330006389 | EC4 | 1.5 | X724 | 1 | 2013-11-15 | DOXORUBICIN | 330001423 | 330003171 | 330006389 |
| 16626021 | 330006389 | EKA | 150 | null | 2 | 2013-11-15 | DACTINOMYCIN | 330001423 | 330003171 | 330006389 |
| 16626022 | 330006389 | EC4 | 1.5 | X724 | 1 | 2013-11-15 | ETOPOSIDE | 330001423 | 330003171 | 330006389 |
| 16626023 | 330006389 | ED301 | 5040 | X721 | 1 | 2013-11-15 | ETOPOSIDE | 330001423 | 330003171 | 330006389 |
| 16626024 | 330006390 | EGQ01 | 200 | X724 | 1 | 2013-07-08 | TOPOTECAN | 330001430 | 330003173 | 330006390 |
| 16626025 | 330006390 | EGU08 | 60 | null | 1 | 2013-07-09 | AZD9150 | 330001430 | 330003173 | 330006390 |
| 16626026 | 330006390 | EGU08 | 2960 | null | 1 | 2013-07-09 | RITUXIMAB | 330001430 | 330003173 | 330006390 |
| 16626027 | 330006394 | EGQ01 | 200 | null | 1 | 2014-12-01 | CYCLOPHOSPHAMIDE | 330001442 | 330003178 | 330006394 |
| 16626028 | 330006394 | EEI00 | 760 | null | 1 | 2014-12-01 | DOXORUBICIN | 330001442 | 330003178 | 330006394 |
| 16626029 | 330006395 | EGQ01 | null | X292 | 1 | 2014-06-10 | TRIAL | 330001442 | 330003178 | 330006395 |
| 16626030 | 330006396 | EEI00 | 0 | x724 | 1 | null | CISPLATIN | 330001484 | 330003179 | 330006396 |
| 16626031 | 330006396 | ETG | 8 | x724 | 5 | null | DAUNORUBICIN | 330001484 | 330003179 | 330006396 |
| 16626032 | 330006396 | ELW | 40 | X729 | 1 | null | VINCRISTINE | 330001484 | 330003179 | 330006396 |
| 16626033 | 330006396 | EXO | 400 | X723 | 1 | null | NOT CHEMO | 330001484 | 330003179 | 330006396 |
| 16626034 | 330006396 | EUZ | 2320 | X724 | 5 | null | VINCRISTINE | 330001484 | 330003179 | 330006396 |
| 16626035 | 330006396 | EK1EN | 6 | X724 | 1 | null | AVELUMAB | 330001484 | 330003179 | 330006396 |
| 16626036 | 330006396 | ED301 | 50 | null | 1 | null | IFOSFAMIDE | 330001484 | 330003179 | 330006396 |
| 16626037 | 330006396 | ERA20 | 1500 | X724 | 1 | null | FLUOROURACIL | 330001484 | 330003179 | 330006396 |
| 16626038 | 330006396 | EW100 | 148 | X724 | 1 | null | DOCETAXEL | 330001484 | 330003179 | 330006396 |
| 16626039 | 330006396 | EGENG | 20 | null | 2 | null | NOT CHEMO | 330001484 | 330003179 | 330006396 |
| 16626040 | 330006400 | EGU08 | 0 | N\A | 1 | 2017-03-14 | NOT CHEMO | 330001533 | 330010193 | 330006400 |
| 16626041 | 330006400 | EE813 | 10 | X721 | 1 | 2017-03-15 | VINCRISTINE | 330001533 | 330010193 | 330006400 |
| 16626042 | 330006400 | EXO | 3840 | X724 | 1 | 2017-03-16 | TOPOTECAN | 330001533 | 330010193 | 330006400 |
| 16626043 | 330006400 | E1UZ0 | 1800 | X724 | 1 | 2017-03-22 | NOT CHEMO | 330001533 | 330010193 | 330006400 |
| 16626044 | 330006400 | EEI00 | 150 | X729 | 1 | 2017-03-23 | NIVOLUMAB | 330001533 | 330010193 | 330006400 |
| 16626045 | 330006403 | ECL01 | 2960 | X724 | 1 | 2013-09-26 | VINCRISTINE | 330001552 | 330010195 | 330006403 |
| 16626046 | 330006403 | EEI00 | 300 | x724 | 1 | 2013-09-26 | STEROID | 330001552 | 330010195 | 330006403 |
| 16626049 | 330006408 | EXO | 575 | X724 | 9 | 2018-02-03 | ETOPOSIDE | 330001567 | 330010197 | 330006408 |
| 16626050 | 330006408 | EEI00 | 100 | X721 | 1 | 2018-02-03 | CYCLOPHOSPHAMIDE | 330001567 | 330010197 | 330006408 |
| 16626051 | 330006408 | EXO | 0.95 | X724 | 2 | 2018-02-03 | CYCLOPHOSPHAMIDE | 330001567 | 330010197 | 330006408 |
| 16626052 | 330006408 | EEI00 | 240 | null | 1 | 2018-02-23 | NOT CHEMO | 330001567 | 330010197 | 330006408 |
| 16626053 | 330006408 | EEI00 | 0 | X729 | 2 | 2018-02-23 | ETOPOSIDE | 330001567 | 330010197 | 330006408 |
| 16626054 | 330006408 | EZ102 | 100 | X722 | 1 | 2018-02-23 | NOT CHEMO | 330001567 | 330010197 | 330006408 |
| 16626055 | 330006408 | EUZ | 2 | null | null | 2018-02-23 | IFOSFAMIDE | 330001567 | 330010197 | 330006408 |
| 16626056 | 330006408 | EW100 | 110 | X721 | 1 | 2018-02-24 | DOCETAXEL | 330001567 | 330010197 | 330006408 |
| 16626057 | 330006408 | EW100 | 108 | X724 | null | 2018-02-25 | DOCETAXEL | 330001567 | 330010197 | 330006408 |
| 16626058 | 330006408 | EW100 | 4000 | X722 | 1 | 2018-02-26 | FLUOROURACIL | 330001567 | 330010197 | 330006408 |
| 16626059 | 330006413 | EXO | 437.5 | X724 | 1 | 2014-02-11 | TOPOTECAN | 330001621 | 330003190 | 330006413 |
| 16626060 | 330006413 | EEI00 | 2400 | null | 1 | 2014-02-12 | NOT CHEMO | 330001621 | 330003190 | 330006413 |
| 16626061 | 330006414 | EGU08 | 562.5 | null | 1 | 2016-10-24 | NOT CHEMO | 330001621 | 330003190 | 330006414 |
| 16626062 | 330006414 | EEI00 | 80 | X721 | 9 | 2016-10-24 | ADI-PEG 20 | 330001621 | 330003190 | 330006414 |